GALE.SW
Galenica AG

Healthcare · Medical Distribution · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

3.20B USD

Market Cap

5.33B USD

Margin of Safety

-66.6%

Intrinsic / Market Ratio

0.60×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

3.61B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

3.20B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

2.79B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

3.20B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

3.20B USD

from the sum above

Market Cap

5.33B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.60×

the ratio the screener ranks by; Margin of Safety -66.6% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 3.61B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)3.84B USD
−②Net Debt Today235.51M USD
+③Growth Value0 USD
=Value3.61B USD

EPV of the Operations (NOPAT over WACC)

3.84B USD

Net debt today

-235.51M USD

Growth Value

0 USD

Value

3.61B USD

①EPV (earnings power value)

3.84B USD

②Net Debt Today

235.51M USD

③Growth Value

0 USD

Market value

Market Cap5.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-47.8%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 3.20B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.89B USD
+②Equity at Year 15, Today1.31B USD
=Value3.20B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.89B USD

②Equity at Year 15, Today

1.31B USD

Market value

Market Cap5.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-66.8%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 2.79B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF2.02B USD
+②Invested Capital at Year 15, Today1.01B USD
−③Net Debt Today235.51M USD
=Value2.79B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

2.02B USD

②Invested Capital at Year 15, Today

1.01B USD

③Net Debt Today

235.51M USD

Market value

Market Cap5.33B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-90.8%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 5.99%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.26×Market Risk Premium 6.00%= 6.04%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 48.66M USDPretax Income 281.16M USD= 17.31%

The tax the interest saves.

Interest Expense =EBIT 298.17M USD−Pretax Income 281.16M USD= 17.01M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 17.01M USDTotal Debt 284.60M USD×(1 − Tax Rate for WACC 17.31%)= 4.94%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 284.60M USDMarket Cap + Total Debt 5.33B USD + 284.60M USD= 5.07%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 94.93%×Cost of Equity 6.04%+Debt Weight 5.07%×Cost of Debt 4.94%= 5.99%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 4.12B USD − Total Liabilities 2.37B USD = Book Value Today 1.75B USD

Total Debt 284.60M USD − Cash and Short-Term Investments 49.09M USD = Net Debt Today 235.51M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.0%at most 5%passes49,824,384 / 49,832,180
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.6%at least -10.0%passes(379.01M USD − 228.98M USD) ÷ 4.12B USD
Price to bookMarket Cap ÷ Book Value Today3.04×at most 3×does not pass5.33B USD ÷ 1.75B USD
Operating marginOperating Income ÷ Revenue5.5%above 10.0%does not pass286.03M USD ÷ 5.23B USD
Revenue growthRevenue ÷ Revenue a Year Before − 120.3%above 10.0%passes5.23B USD / 4.35B USD
Net cash(Cash − Total Debt) ÷ Market Cap-4.4%above -30%passes(49.09M USD − 284.60M USD) ÷ 5.33B USD
Operating efficiencyOperating Income ÷ Gross Profit19.6%above 25.0%does not pass286.03M USD ÷ 1.46B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

88.19 CHF

Enterprise value

5.54B CHF

the provider's own figure

EV / EBITDA

21.66×

Price / book

3.11×

the provider's book

Price / earnings

27.28×

Return on equity

11.4%

the provider's figure, not this page's

Profit margin

3.7%

Revenue growth

7.0%

Analyst target, mean

88.09 CHF

Analysts

5

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

3.89B4.45B4.35B5.23B

Gross profit

1.07B1.24B1.21B1.46B

Operating income

201.79M225.44M226.47M286.03M

EBITDA

operating income before depreciation and amortisation

319.36M364.88M373.45M445.09M

Pretax income

205.67M231.39M237.82M281.16M

Net income

179.12M338.71M202.75M228.98M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

167.96M184.40M189.70M226.54M

R&D

————
Balance sheet, year end

Total assets

2.83B3.55B3.40B4.17B

Total liabilities

1.48B1.80B1.68B2.29B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.35B1.75B1.72B1.87B

Total debt

252.92M280.16M261.42M308.50M

Cash and equivalents

101.88M137.87M143.72M146.04M

Net PP&E

fixed assets after depreciation

516.50M580.74M539.48M646.71M

Working capital

current assets less current liabilities

104.78M310.17M332.55M173.17M
Cash flow

Operating cash flow

256.93M267.90M293.35M379.01M

Capital expenditure

paid out, so below zero

-75.71M-90.65M-80.20M-70.50M

Depreciation and amortisation

108.00M122.25M121.61M146.92M

Free cash flow

operating cash flow plus capital expenditure

181.22M177.25M213.16M308.51M